Hasil Pencarian - Manjunath Krishnappa

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Addressing Irreversibility and Structural Distortion in WS2 Inorganic Fullerene-Like Nanoparticles: Effects of Voltage Cutoff Experiments in Beyond Li+‑Ion Storage Applications

    Addressing Irreversibility and Structural Distortion in WS2 Inorganic Fullerene-Like Nanoparticles: Effects of Voltage Cutoff Experiments in Beyond Li+‑Ion Storage Applications oleh Sonjoy Dey, Arijit Roy, Shakir Bin Mujib, Manjunath Krishnappa, Alla Zak, Gurpreet Singh

    Diterbitkan 2024-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Antifungal Potential of <i>Azotobacter salinestris</i> Strain <i>Azt</i> 31 against Phytopathogenic <i>Fusarium</i> spp. Associated with Cereals

    Antifungal Potential of <i>Azotobacter salinestris</i> Strain <i>Azt</i> 31 against Phytopathogenic <i>Fusarium</i> spp. Associated with Cereals oleh Hanumanthu Nagaraja, Gurikar Chennappa, Nagaraj Deepa, Manjunath Krishnappa Naik, Kadaiah Ajithkumar, Yatgal Sharanappa Amaresh, Premila N. Achar, M. Y. Sreenivasa

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study)

    Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double bli... oleh Manjunath Krishnappa, Kishor Patil, Krupi Parmar, Purav Trivedi, Nirali Mody, Chintan Shah, Khushboo Faldu, Sanjay Maroo, for the PRESS XII study group, Deven Parmar

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    P740: PK, PD AND SAFETY OF FIRST-IN-HUMAN, FIRST-IN-CLASS PHASE I TRIAL (AUR103-101; BHARAT) OF AUR103, AN ORAL CD47 INHIBITOR, IN PATIENTS WITH ADVANCED MALIGNANCIES

    P740: PK, PD AND SAFETY OF FIRST-IN-HUMAN, FIRST-IN-CLASS PHASE I TRIAL (AUR103-101; BHARAT) OF AUR103, AN ORAL CD47 INHIBITOR, IN PATIENTS WITH ADVANCED MALIGNANCIES oleh Manjunath Krishnappa, Divyesh Mandavia, Minish Jain, Mukesh S, Ankit Patel, Anshul Agarwal, Sanjeev Giri, Nirbhay Kumar Tiwari, Saravanan Thiyagarajan, Mamon Dey, Gutta Padmanabha Naidu, Murali Ramachandra, Akhil Kumar

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: